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Liver cancer, both primary and metastatic, is often deemed hope-
less and patients with advanced disease cannot be offered a 
treatment that is completely effective. Surgical resection is the 
treatment of choice, but less than 20% of patients are candidates for 
this treatment. 
Hepatic cryosurgery is a relatively new procedure in which the 
tumor is localized intraoperatively with ultrasound guidance and 
exposed to liquid nitrogen at -196·c. Nine cases have been per-
formed in Hawaii, and we present the first four cases here. Of these 
cases, there were no mortalities and only one patient required blood 
transfusion. All patients currently are alive with up to 11-month 
follow-up. Longer-term studies will be necessary to assess the 
effectiveness of this modality. 
Primary hepatic neoplasms account for more than one million 
deaths a year worldwide. There is considerable geographic varia-
tion-as low as one death per 100,000 in the U.S. and as high as 100/ 
100,000 deaths in parts of Asia and southern Africa. Risk factors for 
hepatoma include the presence of viral hepatitis B and C, exposure 
to certain toxins ( aflatoxins or thorotrast), primary biliary cirrhosis, 
hemochromatosis, and alcoholic liver disease. Any chronic liver 
disease can predispose a patient to liver cancer and 70% of all 
hepatocellular cancers occur in those with cirrhosis.' Typically, 
symptoms occur late and most patients present with advanced 
disease. 
Metastatic liver cancer frequently originates in the gastrointesti-
nal (GI) tract, but can come from any primary tumor in the body. 
Colorectal cancer is the most common GI malignancy that metasta-
sizes to the liver. More than 138,000patients in the U.S. will develop 
colorectal cancer, and 55,000 will die of it yearly. Nearly 70% of 
patients who die of colorectal cancer will have metastatic lesions to 
the liver.2 
The only potentially curative therapy for both primary and sec-
ondary liver cancer is surgical resection and liver transplantation in 
certain circumstances. The magnitude of this problem lies in the fact 
that less than 20% of all patients will be candidates for surgery and 
other therapies, such as chemotherapy, chemo-embolization, 
intrahepatic artery chemotherapy, and percutaneous ethanol injec-
tion, used only for palliative or adjunctive therapies. Hepatic 
cryosurgery is a new surgical treatment used to eradicate disease 
and possibly improve long-term survival. It can be used for 
unresectable lesions because of the presence of multiple lesions, hi-
lobar disease, poor liver reserve, or proximity to major vessels. 
Morbidity and mortality are low and early studies are promising. In 
essence, it increases the number of patients who are surgical 
candidates and provides them with a potential cure. Early studies are 
promising; however, the long-term benefit of this treatment needs 
to be studied. 
-
Methods and Materials 
The four cases of hepatic cryosurgery performed at St Francis 
Medical Center all underwent general anesthesia with placement of 
central venous and arterial catheters for monitoring. Body tempera-
ture was carefully monitored and a Bair Hugger® was used for 
warming. All lesions were biopsied prior to treatment. All proce-
dures were performed using a Cryotech LCS 2000 cryosurgical 
system with intraoperative ultrasound guidance. Various probes 
were used to freeze the tumor with liquid nitrogen to -1so·c to 
-190T: 5 mm, 10 mm, and flat. Each lesion was frozen until a halo 
of normal tissue measuring about 1 em could be seen around the 
tumor on the ultrasound, about 7 to 10 minutes, after which the 
lesion was thawed completely. Each lesion underwent two freeze-
thaw cycles. Areas were carefully inspected for liver cracking and 
hemorrhage; bleeding was controlled with Gelfoam and suture 
ligation. All patients remained in the intensive care unit for the first 
24 hours and were maintained with mannitol and low-dose dopam-
ine to prevent rhabdomyolysis and acute renal insufficiency. Bleed-
ing parameters were monitored closely and liver enzymes were 
obtained daily. An ultrasound of the abdomen was done before the 
patient was discharged. CT scans were used for follow-up at one 
month, three months, and every three months thereafter and tumor 
markers were followed. 
Case One 
A 71-year-old man with Duke's B rectal carcinoma underwent 
abdominoperineal resection in 1991. No evidence ofliver metastases 
was noted and his medical history was notable for non-insulin 
diabetes. He remained completely asymptomatic; a follow-up CT 
scan in September 1994 demonstrated a 2.5 em lesion in the left 
medial segment of the liver, and a 1.0 em lesion in the right lobe. 
Carcinoembryonic antigen or CEA: 2.0 ng/ml; alpha fetoprotein 
was normal. Percutaneous biopsies of these lesions were consistent 
with adenocarcinoma. Chest x-ray and bone scan were negative for 
metastatic disease. Exploration of the abdomen was notable for 
micronodular cirrhosis and two liver lesions: a 3.3 em lesion in the 
left medial segment just adjacent to the falciform ligament and a 1.8 
em lesion in the right lobe of the liver. Frozen section liver biopsies 
were not diagnostic for carcinoma and the abdomen was closed. 
Permanent stains were consistent with hepatocellular carcinoma. 
The patient returned to the operating room 72 hours later and 
underwent hepatic cryosurgery on both lesions. He had no 
intraoperative problems, received no blood transfusions, and was 
discharged six days following the operation. His highest SGOT was 
771. He had mild thrombocytopenia, 75,000/cc, which resolved by 
the time of discharge. At 11 months post-cryosurgery, he is doing 
well and the liver lesions have decreased on serial CT scans. 
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Case Two 
A 52-year-old woman with invasive ductal breast carcinoma 
underwent left modified radical mastectomy and adjuvant chemo-
therapy in 1986. She did well until 1992 when she developed 
superior vena cava syndrome as a result of neck node metastases. 
She also had bony metastases and both areas were radiated. In 1994, 
she underwent autologous bone marrow transplantation with good 
response. She had several metastatic skin nodules that were excised. 
In September 1994, she underwent a routine CT scan of the liver and 
a 3 em mass was noted in the left medial segment. The CT scan of 
the chest/head and bones were all negative. Because the liver mass 
appeared to be an isolated lesion, and she was in good health 
otherwise-working and gaining weight-she was considered for 
hepatic cryosurgery. On December 1, 1994, she underwent explor-
atory laparotomy and had an isolated lesion in the left medial 
segment that measured 3.9 em in the greatest dimension. The biopsy 
was consistent with a breast primary and she underwent cryosurgery 
of the lesion. Although no problems were encountered during 
surgery, 3 U of packed red blood cells was administered postopera-
tively for a subcapsular hematoma. She also had thrombocytopenia 
to 60,000/mm3• She was discharged six days following the proce-
dure but was readmitted a week later with a large right pleural 
effusion and mild dyspnea that were managed with a tube 
thoracostomy and pleurodesis. Transient hyperbilirubinemia was 
detected, probably related to reabsorption of the subcapsular 
hematoma. Eleven months after surgery she is alive and the liver 
lesion is smaller; however, she recently developed brain metastases. 
Case Three 
A 51-year-old woman underwent low anterior resection for mod-
erately well-differentiated adenocarcinoma of the rectum in No-
vember 1993. At the time of surgery, she had four metastatic lesions 
involving both right and left lobes of the liver and ranging from 1.0 
em to 4.0 em. Postoperatively she received multiple courses of 
chemotherapy that included 5-FU and leucovorin. Serial CT scans 
were variable with the lesions sometimes appearing unchanged, and 
at other times much smaller. Cryosurgery was considered, but CT 
scans in November 1994 showed an increase in the largest lesion to 
about 6.0 em. She underwent exploratory laparotomy and an 
intrahepatic arterial catheter was inserted. There was no evidence 
for extrahepatic metastases. She received intrahepatic arterial 
floxuridine and leucovorin and a decrease in lesion size was seen by 
CT scan. On February 28, 1995, she underwent exploratory 
laparotomy which revealed five liver lesions. A 6 em mass in the left 
lateral segment was completely excised with segunentectomy. A 
1.5 em lesion at the edge of the right lobe anteriorly was wedge 
resected. The other three lesions (5.5 em, 1 em, and 1 em) were all 
in the right lobe and each underwent cryoablation. She had no 
perioperative problems, received no transfusions, and was dis-
charged seven days later. She is currently alive and the lesions have 
decreased in size on subsequent CT scans, but she recently has 
developed several small lesions elsewhere in the liver. 
Case Four 
A 65-year-old woman was found to have gall bladder carcinoma 
on elective laparoscopic cholecystectomy for symptomatic 
cholelithiasis. Her past history is otherwise unremarkable. A CT 
scan demonstrated a 1.5 em lesion on the left medial segment of the 
liver. She underwent five courses of systemic chemotherapy with 5-
FU, Adriamycin, and mitomycin-C. After chemotherapy, CT scan 
with arteriograrn/portagram showed no change in the previous 
lesion and a small mass in the area of the cystic duct. On April 6, 
1995, exploratory CT scan with arteriograrn/portagram showed no 
change in the previous lesion and laparotomy showed four sites of 
metastatic disease. A 1.9 em mass in the left medial segment was 
resected. Two small lesions, each less than 1 em (left lateral segment 
and right lobe), were treated with cryosurgery. A 2 em mass near the 
cystic duct stump was also positive for carcinoma and this was 
surgically debulked. 
Cryosurgery could not be performed on this lesion due to the 
proximity of the bile ducts. She had no perioperative problems, 
received no blood transfusions, and was discharged five days 
following the procedure. Her highest SGOT was 7251U/L. She also 
underwent adjuvant radiation therapy to the lesion near the bile duct, 
as well as brachytherapy through a common duct T -tube placed at 
the time of surgery. Her lesions have decreased on subsequent CT 
scans and she is doing well six months after surgery. 
Discussion 
Cryosurgery is an operative procedure whereby a tumor is local-
ized with intraoperative ultrasound guidance and exposed to liquid 
nitrogen at -196·c. Use of ultrasound is especially important as it 
allows detection oflesions less than 2 em which might otherwise be 
missed.3 Cryosurgery has been used to treat both primary and 
metastatic liver cancers which are not resectable by conventional 
means due to multiple lesions, bi-lobar disease, poor liver reserve, 
or proximity to major vessels. 
The biology of cryoablation is such that damage occurs primarily 
due to ice crystal formation. Ice forms in the extracellular fluid and 
with slow cooling, intracellular fluid migrates across an osmotic 
gradient to the extracellular space. This leads to cell shrinkage and 
death. The ice mass is then allowed to thaw and this increases the 
damage to the cells.4 Repeating the freeze-thaw cycle has been 
shown to be more effective than a single cycle. 4-? Other effects of 
freezing include denaturing of lipid-protein complexes which dis-
rupts cell membranes and causes leakage of organelles. Freezing 
also damages the walls of the small vessels, leading to deposition of 
platelets and thrombus formation. After several days, the frozen 
lesion becomes necrotic and separates from the normal liver. It is 
essentially a sterile infarct that eventually becomes encapsulated by 
fibrous tissue.4•8 
The advantages of cryosurgery are related to its low morbidity 
and mortality. Multiple studies have been done with no 
mortalities.4-5•9-10 A review of the literature revealed three known 
deaths-two from hepatic failure and one from cardiac arrest. 7 
Complications include liver cracking and hemorrhage which are 
easily controlled with sutures and packing. Blood loss is consider-
ably less than with a standard liver resection. One unitofblood is the 
average requirement. 5 Cryosurgery can also injure the bile ducts, as 
freezing of the ducts can lead to edema and eventually stenosis.4•11 
Mild myoglobinuria occurs in most patients, and alkalization of the 
urine, low-dose dopamine, adequate hydration, and mannitol have 
been recommended.7 Intraoperatively, patients may have mild 
hypothermia, but this is easily controlled with the use of warming 
devices such as the Bair Hugger®. 12 
To date, results of cryosurgery to the liver have been comparable 
to liver resection. Onik et al reported 57 patients with unresectable 
hepatic metastases and demonstrated a 27% disease-free survival 
with 21-month follow-up. 7 Zhou et al, in a study of 107 patients with 
hepatomas, yielded a 22% survival at five years. In smaller tumors 
(<5 em) survival was 93.3% at one year and 48.8% at five years. 11 
Ravikumar performed cryoablation for either metastatic or primary 
liver cancer in 24 patients, and 24% had a complete response at 14 
monthsY 
Preliminary data also suggest that cryosurgery may be helpful in 
non-colorectal metastases. Rammings et al treated 16 patients with 
-
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disease including development of meta-
static lesions in the brain and elsewhere in 
the liver. (Since the four cases presented 
here, we have performed an additional five 
cases for hepatoma, metastatic breast can-
cer, and metastatic colon cancer. All pa-
tients are alive and without evidence of 
recurrence at two to five months.) Our 
results are consistent with those reported 
in the literature in that cryosurgery is ex-
cellent for controlling liver lesions, but 
lesions can occur elsewhere in the liver.9 
Longer follow-up will be necessary to as-
sess the true benefit of cryosurgery. 
Conclusion 
Fig 1.-Hepatic cryosurgery of a tumor in the right lobe. A larger (1 0 mm) probe (single arrow) is used to create 
an iceball (double arrow) including the tumor and a 1 em rim of normal tissue. Ultrasound guidance is used to both 
locate the tumor and observe c?mpleteness of the freezing process (triple arrow). 
Hepatic cryotherapy with ultrasound 
guidance allows us to treat a greater num-
ber of lesions and lesions not surgically 
resectable with clear margins. Morbidity 
and mortality are minimal. Although the 
prognosis with cryosurgery is not signifi-
cantly better than with liver resection, we 
must consider that we are treating a group 
of patients that has a five-year survival of 
zero. Perhaps the addition of cryotherapy 
will allow us to improve on the dismal 
metastases from ovary, breast, thyroid, and neuroendocrine tumors. 
They demonstrated a decrease in the appropriate tumor markers and 
an improvement in neuroendocrine symptoms. Mean overall sur-
vival was 9.1 months (range 1 to 21 months). 14 Cryoablationcan be 
used to assist in hepatic resection in order to allow clearance of 
tumor margins. 15 At the moment, the results are not much worse than 
liver resection and the morbidity is considerably less. Long-term 
follow-up and controlled studies will be necessary to understand the 
true benefit of this modality. 
Cryotherapy alone can be helpful in liver tumors, but when used 
in combination with other modalities may prove to be more benefi-
cial. Tang et al, in evaluating unresectable primary liver cancers in 
137 patients between 1966 and 1977, noted that the five-year 
survival was zero. In the period between 1978 and 1989, 345 
unresectable liver tumors had a 16.9% five-year survival with the 
use of cytoreduction (hepatic artery ligation, hepatic artery infusion, 
cryotherapy, and/or radiation) and sequential resection. 16 
In our early experience, the four patients have undergone 
cryosurgery for varying tumors including hepatocellular carci-
noma, and metastatic lesions from the rectum, breast, and gall 
bladder. There were no mortalities and only one patient had compli-
cations of a subcapsular hematoma of the liver requiring transfu-
sion. Transfusions were not needed in the other patients. Three of 
the four patients have undergone multi-modality therapy with 
combinations of liver resection, cryosurgery, chemotherapy, 
intraarterial chemotherapy, and radiation. All patients are alive and 
functioning well; however, two patients have had progression of 
-
outlook of metastatic and primary liver cancer, using a technique 
that has minimal morbidity and mortality. 
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